MarketPeel
Insider Trading Intelligence
ND

Nithya Desikan

RYTM
CHIEF COMMERCIAL OFFICER · RHYTHM PHARMACEUTICALS, INC. · CIK 0001714105
FILING MIX · LIFETIME57%/43%
BUYS
4
SELLS
3
TOTAL VALUE
$1.02M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
43,602
AVG SELL PX
$30.00
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Nithya Desikan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-0.37%-4.61%+4.24%+4.24%
14d1+0.00%+3.35%-3.11%+6.46%+6.46%
30d1+100.00%-26.57%-3.74%-22.82%-22.82%
60d1+100.00%-28.26%-6.14%-22.12%-22.12%
90d1+0.00%+4.88%+4.06%+0.82%+0.82%
180d1+100.00%-12.16%+9.79%-21.96%-21.96%
1y1+100.00%-55.91%+31.20%-87.12%-87.12%
2y1+100.00%-23.42%+16.45%-39.87%-39.87%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RYTM · 43,602 shares · as of Aug 31, 2020
030,74061,48192,221122,961SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
FLOW · 4 buys / 3 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
25,000$6.88$172.0K68,602Aug 31, 2020Sep 1, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
25,00097,961Aug 31, 2020Sep 1, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
25,000$30.00$750.0K43,602Aug 31, 2020Sep 1, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASE
Chief Commercial Officer
14,534$6.88$100.0K43,602Aug 11, 2020Aug 13, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
SALE
Chief Commercial Officer
14,534122,961Aug 11, 2020Aug 13, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 30, 2020Jul 2, 2020
RYTM
RHYTHM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 14, 2020Feb 19, 2020
Other insiders · RYTM
Loading peer insiders…
About this filer
CIK 0001714105
ROLE
Chief Commercial Officer
PRIMARY
RYTM
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001714105DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackNithya Desikan — Insider Trading Activity | MarketPeel